WCM Global Growth Limited (ASX:WQG) disclosed its monthly portfolio update as at 30 September 2026, reporting a portfolio return of 2.40% for the month, compared with the MSCI All Country World Index (ex-Australia) benchmark return of 2.07%, with net tangible assets before tax recorded at A$2.060 per share based on issued capital of 279,877,141 shares.
Key Points
- Portfolio return of 2.40% for the month of September 2026, outperforming the benchmark return of 2.07%
- NTA Before Tax of A$2.060 per share; NTA After Tax of A$1.859 per share; month-end closing share price of A$2.080
- Five new positions initiated during the September quarter, including CVS Health, IQVIA Holdings, Atlassian, Palantir Technologies and Samsung Electronics
- Fully franked annual dividend of A8.81 cents per share; dividends paid quarterly
- Portfolio allocated 40% to cyclical growth, 32% to defensive growth and 28% to secular growth at quarter end
September 2026 Portfolio Performance Figures
According to the filing, the portfolio delivered a one-month return of 2.40% against the benchmark return of 2.07%, generating value added of 0.33% for the month. Over three years, the portfolio returned 23.64% annualised versus the benchmark's 19.32%, and since the company's inception date of 21 June 2017, the portfolio has returned 15.72% annualised compared with the benchmark's 13.55%. The five-year annualised portfolio return was 11.65% against the benchmark's 12.98%. Portfolio returns are calculated in Australian dollars, before expenses and after investment management and performance fees, and include the reinvestment of dividends and income.
Top Holdings and Sector Positioning at 30 September 2026
Taiwan Semiconductor held the largest portfolio weighting at 6.53%, followed by Siemens Energy at 4.80%, Rolls-Royce Holdings at 4.29%, Seagate Technology Holdings at 4.22%, and Amazon.com at 3.94%. Microsoft Corp, Meta Platforms and Illumina each represented weightings of 3.66%, 3.56% and 3.54% respectively. Saab and Samsung Electronics each accounted for 2.82%. The filing stated that stock selection was a positive contributor to relative performance during the month, with the strongest contribution from the Communication Services, Health Care and Industrials sectors.
Portfolio Changes During the September Quarter
The filing disclosed that five new positions were initiated during the September quarter. Within the Health Care sleeve, AstraZeneca and Medline were exited in favour of CVS Health and IQVIA Holdings. Enterprise software companies Atlassian and Palantir Technologies were added, along with Samsung Electronics, as part of a deliberate shift towards a more balanced mix of AI exposures. The portfolio holds between 20 and 40 stocks with a focus on global companies primarily in the Consumer, Technology and Health Care sectors. Typical cash allocation is disclosed as between 0% and 7%, with management fees of 1.25% per annum and administration fees of 0.10% per annum.



Please wait processing your request...